Prognosis of different types of atrial fibrillation in the primary angioplasty era

Coronary Artery Disease

Volumn 23, Issue 8, 2012, Pages 511-516

  Viliani, Dafne ^a   Vivas, David ^a   Chung, Monica ^a   Pérez Vizcayno, María J ^a   Hernández Antolín, Rosana ^a   Bañuelos, Camino ^a   Escaned, Javier ^a   Fernández Ortiz, Antonio ^a   Jiménez Quevedo, Pilar ^a   Vilacosta, Isidre ^a   MacAya, Carlos ^a   Alfonso, Fernando ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

acute myocardial infarction; arrhythmias; coronary artery disease; percutaneous coronary intervention; supraventricular tachycardias

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ANGIOGRAPHY; ANTERIOR MYOCARDIAL INFARCTION; ARTICLE; BLEEDING; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CORONARY STENT; DEATH; DISEASE ASSOCIATION; ELECTROCARDIOGRAPHY; FEMALE; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART REINFARCTION; HOSPITAL ADMISSION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; QRS COMPLEX; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

AGED; ATRIAL FIBRILLATION; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HOSPITAL MORTALITY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SPAIN; STROKE VOLUME; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84869509524     PISSN: 09546928     EISSN: 14735830     Source Type: Journal    
DOI: 10.1097/MCA.0b013e328358a5d2     Document Type: Article

References (26)

1. Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, et al.; European Heart Rhythm Association, European Association for Cardio-Thoracic Surgery. Guidelines for the management of atrial fibrillation: the Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010; 31:2369-2429.
2. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 2006; 48:149-246.
3. Schmitt J, Duray G, Gersh BJ, Hohnloser SH. Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications. Eur Heart J 2009; 30:1038-1045.
4. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998; 98:946-952.
5. Asanin M, Perunicic J, Mrdovic I, Matic M, Vujisic-Tesic B, Arand-Jelovic A, et al. Prognostic significance of new atrial fibrillation and its relation to heart failure following acute myocardial infarction. Eur J Heart Fail 2005; 7:671-676.
6. Pederson OD, Baggar H, Kober L, Torp-Pedersen C. The occurrence and prognostic significance of atrial fibrillation/flutter following acute myocardial infarction. Eur Heart J 1999; 20:748-754.
7. Rathore SS, Berger AK,Weinfurt KP, Schulman KA, Oetgen WJ, Gersh BJ, et al. Acute myocardial infarction complicated by atrial fibrillation in the elderly: prevalence and outcomes. Circulation 2000; 101:969-974.
8. Behar S, Zahavi Z, Goldbourt U, Reicher-Reiss H. Long-term prognosis of patients with paroxysmal atrial fibrillation complicating acute myocardial infarction. SPRINT Study Group. Eur Heart J 1992; 13:45-50.
9. Pizzetti F, Turazza FM, Franzosi MG, Barlera S, Ledda A, Maggioni AP, et al. Incidence and prognostic significance of atrial fibril-lation in acute myocardial infarction: the GISSI-3 data. Heart 2001; 86:527-532.
10. Eldar M, Canetti M, Rotstein Z, Boyko V, Gottlieb S, Kaplinsky E, Behar S. Significance of paroxismal atrial fibrillation complicating acute myocardial infarction in the thrombolytic era: SPRINT and thrombolytic survey groups. Circulation 1998; 97:965-970.
11. Køber L, Swedberg K, McMurray JJV, Pfeffer MA, Velazquez EJ, Diaz R, et al. Previously known and newly diagnosed atrial fibrillation: a major risk indicator after a myocardial infarction complicated by heart failure or left ventricular dysfunction. Eur J Heart Fail 2006; 8:591-598.
12. Vivas D, Pé rez-Vizcayno MJ, Herná ndez-Antol?́n R, Ferná ndez-Ortiz A, Bañ uelos C, Escaned J, et al. Prognostic implications of bundle branch block in patients undergoing primary coronary angioplasty in the stent era. Am J Cardiol 2010; 105:1276-1283.
13. Van de Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V, et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2008; 29:2909-2945.
14. Antman EM, Hand M, Armstrong PW, Bates ER, Green LA, Halasyamani LK, et al. 2007 Focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines: developed in collaboration with the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to review new evidence and update the ACC/AHA 2004 guidelines for the management of patients with STelevation myocardial infarction, writing on behalf of the 2004 Writing Committee.
15. Kinjo K, Sato H, Sato H, Ohnishi Y, Hishida E, Nakatani D, et al. Prognostic significance of atrial fibrillation/atrial flutter in patients with acute myocardial infarction treated with percutaneous coronary intervention. Am J Cardiol 2003; 92:1150-1154.
16. Lau DH, Huynh LT, Chew DP, Astley CM, Soman A, Sanders P. Prognostic impact of types of atrial fibrillation in acute coronary syndromes. Am J Cardiol 2009; 104:1317-1323.
17. Zijlstra F, Hoorntje JC, de Boer MJ, Reiffers S, Miedema K, Ottervanger JP, et al. Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1999; 341:1413-1419.
18. Grines CL, Browne KF, Marco J, Rothbaum D, Stone GW, O'Keefe J, et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med 1993; 328:673-679.
19. Saczynski JS, McManus D, Zhou Z, Spencer F, Yarzebski J, Lessard D, et al. Trends in atrial fibrillation complicating acute myocardial infarction. Am J Cardiol 2009; 104:169-174.
20. Wong CK, White HD, Wilcox RG, Criger DA, Califf RM, Topol EJ, et al. New atrial fibrillation after acute myocardial infarction independently predicts death: the GUSTO-III experience. Am Heart J 2000; 140: 878-885.
21. Jabre P, Jouven X, Adnet F, Thabut G, Bielinski SJ, Weston SA, Roger VL. Atrial fibrillation and death after myocardial infarction: a community study. Circulation 2011; 123:2094-2100.
22. Crenshaw BS,Ward SR, Granger CB, Stebbins AL, Topol EJ, Califf RM; for the GUSTO-I trial investigators Atrial fibrillation in the setting of acute myocardial infarction: the GUSTO-I experience. Global utilization of streptokinase and TPA for occluded coronary arteries. J Am Coll Cardiol 1997; 30:406-413.
23. Siu CW, Jim MH, Ho HH, Miu R, Lee SWL, Lau CP, et al. Transient atrial fibrillation complicating acute inferior myocardial infarction: implications for future risk of ischemic stroke. Chest 2007; 132:44-49.
24. Jabre P, Roger VL, Murad MH, Chamberlain AM, Prokop L, Adnet F, et al. Mortality associated with atrial fibrillation in patients with myocardial infarction: a systematic review and methanalysis. Circulation 2011; 123:1587-1593.
25. Mehta RH, Dabbous OM, Granger CB, Kuznetsova P, Kline-Rogers EM, Anderson FA, et al.; GRACE Investigators. Comparison of outcomes of patients with acute coronary syndromes with and without atrial fibrillation. Am J Cardiol 2003; 92:1031-1036.
26. Lehto1 M, Snapinn S, Dickstein K, Swedberg K, Nieminen MS; on behalf of the OPTIMAAL investigators Prognostic risk of atrial fibrillation in acute myocardial infarction complicated by left ventricular dysfunction: the OPTIMAAL experience. Eur Heart J 2005; 26:350-356.